Alzheimer's Disease and Dementia
Medicare Coverage of Aducanumab for Alzheimer Disease: The Impact of the Decision
Neurobehavioral Disorders
Exploring the Link Between Academic Stress and Mental Health in College Students
- Amyloid-Beta Levels Fall During Major Depressive Episodes and Rise After Remission
- Neurological vs Psychiatric Outcomes After COVID-19: Which Risks Last Longer?
- Viloxazine Plus Caffeine Increases Insomnia Likelihood in Adults With ADHD
- Children With Obstructive Sleep-Disordered Breathing Experience Care Inequities
- Treatment Benefits Adults With Major Depression, With or Without Childhood Trauma
- In Utero Exposure to Natural Disaster Associated With Increased Risk for Child Psychopathology
- Bariatric Surgery Associated With Lasting, Clinically Important Improvements in Pain
- At Least 4.4 Million Americans Have Gotten Updated COVID-19 Boosters
- Repetitive Neuromodulation Leads to Memory Improvements in Older Adults
- Metformin, Ivermectin, and Fluvoxamine Do Not Prevent Severe COVID-19 Outcomes
- Psychiatrists Adept at Diagnosing and Treating Neurodegenerative Diseases
- Xanomeline-Trospium Improves PANSS Scores for Patients With Schizophrenia
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
Remdesivir Safe Despite Advanced CKD, Study Finds
Efficacy of Ciprofloxacin Plus Fluocinolone Acetonide for Acute Otitis Externa
Advanced Retinitis Pigmentosa Can Benefit From Full-Field Stimulus Threshold Testing
Tool Evaluates Feelings of Pain Invalidation for Patients With Chronic Pain
How Does Solriamfetol Treatment for OSA and Narcolepsy Affect Body Weight?
